Search
Now showing items 1-5 of 5
Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use
(United States. Patent and Trademark Office, 2012-02-28)
The present invention provides MSCRAMM® proteins from S. aureus which are putative highly-expressed antigens from methicillin-resistant S. aureus, including communit-associated MRSA (CA-MRSA), and these antigens can thus ...
SDRD protein from Staphylococcus aureus and diagnostic kits including same
(United States. Patent and Trademark Office, 2010-11-16)
An isolated extracellular matrix-binding protein, designated as SdrD and its corresponding amino acid and nucleic acid sequences and motifs are described. The proteins, peptides, fragments thereof or antigenic portions ...
SDRE protein from Staphylococcus aureus and diagnostic kits including same
(United States. Patent and Trademark Office, 2010-12-21)
An isolated extracellular matrix-binding protein, designated as SdrE and its corresponding amino acid and nucleic acid sequences and motifs are described. The proteins, peptides, fragments thereof or antigenic portions ...
Polypeptides and polynucleotides from coagulase-negative staphylococci
(United States. Patent and Trademark Office, 2010-05-04)
Methods for treating or preventing infections from coagulase-negative staphylococci using proteins and polypeptides from coagulase-negative staphylococcal bacteria such as S. epidermidis, including proteins designated SdrF, ...
SdrC protein from Staphylococcus aureus and diagnostic kits including same
(United States. Patent and Trademark Office, 2010-10-19)
An isolated extracellular matrix-binding protein, designated as SdrC and its corresponding amino acid and nucleic acid sequences and motifs are described. The proteins, peptides, fragments thereof or antigenic portions ...